Clinical Trial: A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022

U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07317713) titled 'A Two-decade Mortality Risk Analysis of Gastrointestinal Carcinoid Neoplasms: an Updated SEER-based Study 2000-2022' on Dec. 19, 2025.

Brief Summary: Carcinoid tumors are rare neuroendocrine tumors with slowly progressive course with the sites are small intestine accounting for 45%, rectum (20%), appendix (17%), colon (11%), and stomach (7%). This study focus on the mortality risk analysis for GI carcinoids due to data insufficiency in the literature.

Study Start Date: Dec. 01, 2000

Study Type: OBSERVATIONAL

Condition: Carcinoid Tumor

Recruitment Status: COMPLETED

Sponsor: Suez Canal University

Information provided by (Respons...